retatrutide trial dose highest of in adults with obesity over 104 weeks in the group had 30.3% weight loss. Nearly 2/3 reached BMI < 30 1 in 3 reached BMI < 25 Retatrutide Dosing: Early Clinical – Retatrutide (GLP-3) Results: What Trials

I consider blood work the single most important harm reduction practice

There are no established doses for the use of antidiabetic drugs in the treatment of prediabetes

Prudent practice requires that clinicians and patients understand the condition, recognize symptoms early, and treat sudden vision loss as urgent, regardless of whether a specific drug is the ultimate cause

Folic acid and prenatal multivitamins fuel egg and sperm DNA and reduce neural-tube defect risk

Neuroprotective effects: Some studies suggest that KPV may have neuroprotective properties, potentially reducing neuroinflammation and supporting neural health

By making cells more sensitive to the growth hormone thats already circulating in your body, the peptide could theoretically make your natural repair processes more efficient